Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 responsive T cell numbers and anti-Spike IgG levels are both associated with protection from COVID-19: A prospective cohort study in keyworkers
David Wyllie, Hayley E. Jones, Ranya Mulchandani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan, José Mateus, Yu Kato, et al.
Science (2021) Vol. 371, Iss. 6529
Open Access | Times Cited: 2727
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer, et al.
Nature Medicine (2020) Vol. 27, Iss. 2, pp. 270-278
Open Access | Times Cited: 565
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 530
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Madhumita Shrotri, Annalan M D Navaratnam, Vincent Nguyen, et al.
The Lancet (2021) Vol. 398, Iss. 10298, pp. 385-387
Open Access | Times Cited: 402
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Leo Swadling, Mariana O. Diniz, Nathalie Schmidt, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 110-117
Open Access | Times Cited: 356
T cell response to SARS-CoV-2 infection in humans: A systematic review
Madhumita Shrotri, May C I van Schalkwyk, Nathan Post, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245532-e0245532
Open Access | Times Cited: 351
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
Maria Prendecki, Candice Clarke, Jonathan C. Brown, et al.
The Lancet (2021) Vol. 397, Iss. 10280, pp. 1178-1181
Open Access | Times Cited: 318
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold, et al.
Nature Medicine (2020) Vol. 27, Iss. 2, pp. 279-288
Open Access | Times Cited: 314
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
Rhia Kundu, Janakan Sam Narean, Lulu Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 292
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
Shirin Kalimuddin, C Tham, Martin Qui, et al.
Med (2021) Vol. 2, Iss. 6, pp. 682-688.e4
Open Access | Times Cited: 194
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
SARS-CoV-2-specific T cells in infection and vaccination
Antonio Bertoletti, Nina Le Bert, Martin Qui, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2307-2312
Open Access | Times Cited: 150
COVID‐19 Vaccine Response in People with Multiple Sclerosis
Emma Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Annals of Neurology (2021) Vol. 91, Iss. 1, pp. 89-100
Open Access | Times Cited: 143
Understanding T cell responses to COVID-19 is essential for informing public health strategies
Santosha A. Vardhana, Lance Baldo, William G. Morice, et al.
Science Immunology (2022) Vol. 7, Iss. 71
Open Access | Times Cited: 118
Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals
Anthony T. Tan, Joey Ming Er Lim, Nina Le Bert, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 17
Open Access | Times Cited: 116
SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin C. Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 88
Viral vector vaccines
Naina McCann, Daniel O’Connor, Teresa Lambe, et al.
Current Opinion in Immunology (2022) Vol. 77, pp. 102210-102210
Open Access | Times Cited: 70
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection
Jennifer M. Dan, José Mateus, Yu Kato, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 122
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers
Ricardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 1, pp. 70-80
Open Access | Times Cited: 79
Decay of Fc-dependent antibody functions after mild to moderate COVID-19
Wen Shi Lee, Kevin J. Selva, Samantha K. Davis, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 6, pp. 100296-100296
Open Access | Times Cited: 78
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
Antonio Bertoletti, Anthony T. Tan, Nina Le Bert
Oxford Open Immunology (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 74
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
Candice Clarke, Maria Prendecki, Amrita Dhutia, et al.
Kidney International (2021) Vol. 99, Iss. 6, pp. 1470-1477
Open Access | Times Cited: 69
Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study
Nathanaël Hozé, Juliette Paireau, Nathanaël Lapidus, et al.
The Lancet Public Health (2021) Vol. 6, Iss. 6, pp. e408-e415
Open Access | Times Cited: 62
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective
Colin Funk, Craig A. Laferrière, Ali Ardakani
Viruses (2021) Vol. 13, Iss. 3, pp. 418-418
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top